BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31656053)

  • 1. Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2020 Apr; 115(4):768-777. PubMed ID: 31656053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding factors that predict treatment-resistant depression: Results of a cohort study.
    Cepeda MS; Reps J; Ryan P
    Depress Anxiety; 2018 Jul; 35(7):668-673. PubMed ID: 29786922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden.
    Reutfors J; Andersson TM; Brenner P; Brandt L; DiBernardo A; Li G; Hägg D; Wingård L; Bodén R
    J Affect Disord; 2018 Oct; 238():674-679. PubMed ID: 29966932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional associations between treatment-resistant depression and general medical conditions.
    Madsen KB; Momen NC; Petersen LV; Plana-Ripoll O; Haarman BCM; Drexhage H; Mortensen PB; McGrath JJ; Munk-Olsen T
    Eur Neuropsychopharmacol; 2021 Oct; 51():7-19. PubMed ID: 34023798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder.
    Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
    Curr Med Res Opin; 2021 Jan; 37(1):123-133. PubMed ID: 33124940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study.
    Brenner P; Nygren A; Hägg D; Tiger M; O'Hara M; Brandt L; Reutfors J
    Int J Psychiatry Clin Pract; 2022 Sep; 26(3):251-258. PubMed ID: 34851214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study.
    Reutfors J; Andersson TM; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
    Arch Suicide Res; 2021; 25(3):424-438. PubMed ID: 31774374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.
    Lähteenvuo M; Taipale H; Tanskanen A; Rannanpää S; Tiihonen J
    J Affect Disord; 2022 Jul; 308():236-242. PubMed ID: 35398108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.
    Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
    BMC Psychiatry; 2020 May; 20(1):232. PubMed ID: 32404073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause-specific life years lost in individuals with treatment-resistant depression: A Danish nationwide register-based cohort study.
    Madsen KB; Plana-Ripoll O; Musliner KL; Debost JP; Petersen LV; Munk-Olsen T
    J Affect Disord; 2021 Feb; 280(Pt A):250-257. PubMed ID: 33220561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment resistant depression in women with peripartum depression.
    Cepeda MS; Kern DM; Nicholson S
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):323. PubMed ID: 31477032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant resistance in adolescents with major depressive disorder: A nationwide longitudinal study.
    Chen LC; Chen YH; Bai YM; Chen TJ; Chen MH; Su TP
    J Affect Disord; 2020 Feb; 262():293-297. PubMed ID: 31733920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-demographic and clinical risk factors of treatment-resistant depression: A Danish population-based cohort study.
    Gronemann FH; Jorgensen MB; Nordentoft M; Andersen PK; Osler M
    J Affect Disord; 2020 Jan; 261():221-229. PubMed ID: 31655377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
    Chiappini S; d'Andrea G; De Filippis S; Di Nicola M; Andriola I; Bassetti R; Barlati S; Pettorruso M; Sensi S; Clerici M; Dell'Osso B; Vita A; Martinotti G
    Eur Neuropsychopharmacol; 2023 Sep; 74():15-21. PubMed ID: 37148637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan.
    Huang WL; Chiang CL; Wu CS; Liao SC; Chien TH; Tseng CH; Tang CH
    J Affect Disord; 2022 Dec; 319():40-47. PubMed ID: 36096374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.
    Huang SS; Chen HH; Wang J; Chen WJ; Chen HC; Kuo PH
    BMC Psychiatry; 2020 Nov; 20(1):541. PubMed ID: 33203427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.